Trial intelligence / Profile preview

Cyclosporine A in Duchenne Muscular Dystrophy

DRKS00000445Phase 3Completed

Sponsor
Universitätsklinikum Freiburg
Start
Jun 2010
Modality
Small Molecules, Peptides
Countries
3
01

Overview

A Phase 3 trial of cyclosporine in Duchenne muscular dystrophy (DMD), sponsored by Universitätsklinikum Freiburg. Started Jun 2010; status: completed.

02

Drugs

cyclosporine
03

Conditions

Duchenne muscular dystrophy (DMD)

Beyond the preview

Go deeper on DRKS00000445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call